| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |